Pharvaris (PHVS) Change in Receivables (2025 - 2026)
Pharvaris posted quarterly Change in Receivables of -$335027.6 for Q1 2026, down 154.22% year-on-year from $617925.2 in Q1 2025, and down 154.22% on a QoQ basis from -$131787.4 in Q1 2025.
Pharvaris (PHVS) has 2 years of Change in Receivables data on file, last reported at -$335027.6 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Pharvaris | 267.74 Mn | -73.74 Mn | - | -335,027.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -335,027.60 |
| Mar 31, 2026 | -335,027.60 |
| Mar 31, 2025 | -131,787.45 |
| Mar 31, 2025 | -131,787.45 |